Biosimilars User Fee Talks Agree on Development Fee Amounts
The FDA and biosimilars industry have agreed to a product development fee set at 10 percent of each year’s prescription drug marketing application fee, but the FDA is still working to define the fee structure.
300 N. Washington St., Suite 200, Falls Church, VA 22046, USA.
Phone (703) 538-7600 - Fax (703) 538-7676 - Toll free (888) 838-5578.
Copyright by FDAnews. All rights reserved. Do not duplicate or redistribute in any form.